Here, we tested whether reactivation of p53 using Navtemadlin in a mouse melanoma cell line, B16-F10, would induce tumor growth arrest and found that p53+/+ cells were indeed arrested in a dose-dependent manner. Here, TP53 is linked to melanoma.